Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.02.13.705725

INPP5E interactome reveals novel connections to growth factor signaling

Abstract

Primary cilia are sensory cell membrane protrusions whose malfunction causes diseases known as ciliopathies. Joubert syndrome (JBTS) is a rare recessive ciliopathy causing brain malformations and kidney cysts, among other manifestations. A key player in JBTS is INPP5E, a ciliary phosphoinositide lipid phosphatase. Although INPP5E regulates ciliary growth factor signaling, the molecular mechanisms remain poorly understood. Herein, we show that a constitutively active growth factor receptor (PDGFR-D842V) stimulates INPP5E tyrosine phosphorylation, as does the SRC tyrosine kinase. INPP5E tyrosine phosphorylation did not affect its enzyme activity but was associated with stronger binding to SH3GL1, an endocytic regulator, and SNX9, a phosphoinositide-binding protein involved, like INPP5E, in growth factor-induced ciliary ectovesicle release. Our INPP5E interactomic studies identified other growth factor signaling regulators, including among others: SIN1 (the phosphoinositide-binding subunit of the mTORC2 complex), STRAP (a TGF{beta} and PI3K/AKT signaling regulator), GRB2 (a growth factor receptor adaptor) and the JBTS-associated proteins AHI1 and NPHP1. Moreover, INPP5E strongly interacted with the phosphopeptide-binding 14-3-3 proteins, and did so only in presence of serine-85, a phosphorylated INPP5E residue. Lastly, we found that INPP5E differentially regulates two cilium-dependent growth factor signaling pathways in fibroblasts. Thus, while INPP5E downregulated PDGF-induced AKT phosphorylations, it upregulated TGF{beta}-induced SMAD2 and ERK phosphorylations. Altogether, our work provides important clues on the cilia-dependent actions of growth factors, with implications for ciliopathies like JBTS.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Martin-Morales, R., Barbeito, P., Sierra-Rodero, B., Jimenez, L., Schroder Holm, M., Cilleros-Rodriguez, D., Ebert, L. K., Cortabarria, M., Pedersen, L. B., Badano, J. L., Irigoin, F., Schermer, B., Link, W., Christensen, S. T., Garcia-Gonzalo, F. R.. 2026-02-15. INPP5E interactome reveals novel connections to growth factor signaling. https://doi.org/10.64898/2026.02.13.705725

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Biochemical reassessment of the activation of PANK1 by SGLT2 inhibitors

Although SGLT2 inhibitors (SGLT2i) show cardiovascular benefits in addition to glycemic control, their molecular target for cardiovascular effect remains unclear. A recent study reported that two SGLT2i, empagliflozin and dapagliflozin, directly activate pantothenate kinase 1 (PANK1), which mediate their cardioprotective effect. PANK1 phosphorylates pantothenate with ATP to yield 4'-phosphopantothenate and ADP, representing the rate-limiting enzyme of coenzyme A (CoA) biosynthesis. We therefore reassessed this claim using purified recombinant human PANK1. The malachite green assay detected free inorganic phosphate (Pi) but neither ADP nor 4'-phosphopantothenate and its signals do not reflect PANK1 activity. In the ADP-Glo assay, empagliflozin and dapagliflozin did not stimulate PANK1 under either basal conditions or acetyl-CoA feedback inhibition, while the activator PZ-2891 enhanced the activity of PANK1. These results show that SGLT2i do not directly activate PANK1, challenging the proposed PANK1-dependent cardioprotection mechanism.

biochemistry↗

Experimental and computational mapping reveals preferential nanobody targeting of the intracellular cavity of the amino acid transporter BasC

Nanobodies are valuable tools for stabilizing and investigating membrane transporters, but the systematic characterization of large nanobody collections remains experimentally demanding. Here, we combined biochemical and transport assays, experimental structural data and AlphaFold3 modelling to characterize a repertoire of 29 nanobodies targeting the bacterial amino acid transporter BasC. By exploiting the random orientation and asymmetric apparent substrate affinities of BasC in proteoliposomes, comparison of nanobody-mediated influx and efflux inhibition enabled experimental assignment of binding sidedness. The collection showed a marked bias towards inhibition from the intracellular face, whereas only two, Nb58 and Nb78, were identified as extracellular binders. Compatibility assays and a 6.1 [A] crystallographic map of the BasC-Nb53-Nb58 complex supported the simultaneous binding of Nb53 and Nb58 to opposite sides of the transporter and validated the functional sidedness assignment. AlphaFold3 generated high-confidence interaction models for 16 of the 29 complexes. Ten of these models targeted the large intracellular cavity, revealing recurrent epitope clusters. The predicted binding modes of Nb53, Nb71 and Nb74 agreed with available experimental structures, supporting the accuracy of these predictions. Notably, these three nanobodies had previously provided the most informative structural and smFRET data. Our results show that transport-based sidedness measurements together with confidence-filtered structural predictions can define the functional and structural landscape of a nanobody repertoire. This integrated approach may provide a virtual structural screening strategy to prioritize nanobodies, identify dominant epitope regions and select potentially compatible combinations for experimental and structural studies.

biochemistry↗

Intraspecific glucosinolate chemodiversity in Cardamine hirsuta

Within some plant species, a high intraspecific chemical variation, termed chemodiversity, can be found in the composition of specialized metabolites. For Brassicales, glucosinolates are highly characteristic. Their composition is genetically determined but variation has been found within species and between organs in different species. Cardamine hirsuta is increasingly being used as genetic model species, but until now, little was known about its genetically-based variation in glucosinolates. Thus, we aimed to characterize glucosinolate profiles, their putative genetic variation and their chemodiversity in established accessions and wild-collected material. We analyzed the glucosinolate profiles of leaves and roots from offspring, grown under standardized conditions, of 18 accessions collected in nine countries. Glucosinolates were quantified by HPLC-DAD and identities were confirmed by UHPLC-QToF-MS/MS. Glucosinolate composition was analyzed in biosynthetic terms, compared across samples with principal component analysis and chemodiversity was quantified as glucosinolate richness and Shannon diversity. In total, 14 glucosinolates were confirmed across samples. Two main sources of variation among accessions were the relative levels of but-3-enyl- versus pent-4-enylglucosinolate and of benzylglucosinolate versus phenethylglucosinolate. An almost universal presence of 1-methoxyindol-3-ylmethylglucosinolate in roots but not leaves was observed, along with quantitative contrasts between leaves and roots. The glucosinolate composition varied profoundly among accessions and between leaves and roots, while offspring within accessions were mostly consistent in their profiles. Even accessions collected in close proximity produced distinct profiles, with no clear separation along latitude or longitude. Our study highlights two independent and chemically simple traits of apparently genetic nature, namely the extent of chain elongation of methionine-derived and of phenylalanine-derived glucosinolates. Their independent occurrence is a main factor shaping the glucosinolate profiles among accessions. High variation was also observed at a local scale, highlighting complex genetic variation in glucosinolate biosynthesis in the species throughout Europe. Moreover, within individuals different organs showed clearly distinct profiles, indicating organ-specific biosynthesis. The genetic basis and ecological consequences of this variation need to be explored in future studies.

biochemistry↗